Company
Anew Labs is an organisation working in artificial intelligence. This page collects every Aivio News story about Anew Labs, together with its models and recorded benchmark results.
ByteDance's spun-off AI drug discovery unit Anew Labs raises $290m in its first outside round
ByteDance keeps a majority stake, according to Reuters' sources. The unit has four drug candidates and no approved medicines, and neither company has commented on the valuation.
Privacy preferences
We use necessary cookies to run this site. With your consent we also use advertising cookies. You can change your choice at any time. Cookie Policy · Privacy Policy
